早期直肠癌器官保留的研究进展  

Research progress in organ preservation strategies for early rectal cancer

作　　者：宋子甲 赵任[1] SONG Zijia;ZHAO Ren(Department of General Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)

机构地区：[1]上海交通大学医学院附属瑞金医院普外科,上海200025

出　　处：《外科理论与实践》2024年第3期211-216,共6页Journal of Surgery Concepts & Practice

摘　　要：探讨早期直肠癌器官保留策略的研究进展。尽管全直肠系膜切除术(TME)是标准治疗方法,但由于其可能导致生活质量下降,越来越多的关注转向器官保留策略。讨论早期直肠癌的精确分期方法,并针对cT1N0M0和cT2N0M0病人提出具体的器官保留方案。另外,对于错配修复缺陷(dMMR)/高度微卫星不稳定(MSI-H)病人,免疫疗法显示出巨大的潜力。总结当前研究成果,为临床医师在治疗早期直肠癌时提供有关器官保留的指导建议。This review explored recent advancements in organ preservation strategies for early rectal cancer.Although total mesorectal excision(TME) remains the standard treatment,there is a growing interest in organ preservation approaches due to the potential decline in quality of life associated with TME.We discussed precise staging methods for early rectal cancer and proposed specific organ preservation protocols for cT1N0M0 and cT2N0M0 patients.Additionally,immunotherapy has shown significant potential for patients with deficient mismatch repair/microsatellite instability-high(dMMR/MSI-H) status.This review summarized current research findings and provided guidance for clinicians on organ preservation options when treating early rectal cancer.

关 键 词：早期直肠癌 器官保留 观察等待策略 全程新辅助治疗 

分 类 号：R735.37[医药卫生—肿瘤]